JOP20200267A1 - طريقة لتحضير (4s)-4-(4-سيانو-2-ميثوكسي فنيل)-5- إيثوكسي-8،2- ثنائي ميثيل-4،1- ثنائي هيدرو-1-6-نفثيريدين-3-كربوكس-اميد عن طريق فصل راسيمات بواسطة استرات حمض طرطريك دياستريومرية - Google Patents
طريقة لتحضير (4s)-4-(4-سيانو-2-ميثوكسي فنيل)-5- إيثوكسي-8،2- ثنائي ميثيل-4،1- ثنائي هيدرو-1-6-نفثيريدين-3-كربوكس-اميد عن طريق فصل راسيمات بواسطة استرات حمض طرطريك دياستريومريةInfo
- Publication number
- JOP20200267A1 JOP20200267A1 JOP/2020/0267A JOP20200267A JOP20200267A1 JO P20200267 A1 JOP20200267 A1 JO P20200267A1 JO P20200267 A JOP20200267 A JO P20200267A JO P20200267 A1 JOP20200267 A1 JO P20200267A1
- Authority
- JO
- Jordan
- Prior art keywords
- preparation
- naphthyridine
- methoxyphenyl
- dihydro
- ethoxy
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 238000000926 separation method Methods 0.000 title abstract 2
- 150000003899 tartaric acid esters Chemical class 0.000 title abstract 2
- BTBHLEZXCOBLCY-QGZVFWFLSA-N (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide Chemical compound C1([C@@H]2C(=C(C)NC=3C(C)=CN=C(C2=3)OCC)C(N)=O)=CC=C(C#N)C=C1OC BTBHLEZXCOBLCY-QGZVFWFLSA-N 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
يتعلق الاختراع الحالي بطريقة جديدة ومحسنة لتحضير (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide بالصيغة (I) (I) ويتعلق أيضا بتحضير المصاوغ المرآتي enantiomer (Ia) بواسطة فصل راسيمات باستخدام esters حمض tartaric مستبدلة بمركب كيرالي بالصيغ العامة (IIIa) و(IIIb) (Ia) (IIIa) (IIIb) حيث Ar يمثل جذر عطري متغاير أو عطري مستبدل أو غير مستبدل.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18169052.0A EP3560922A1 (de) | 2018-04-24 | 2018-04-24 | Verfahren zur herstellung von (4s)- 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridin-3-carbox-amid durch racemat-spaltung mittels diastereomerer weinsäureester |
PCT/EP2019/054941 WO2019166532A1 (en) | 2018-03-01 | 2019-02-28 | 2,4-diaminoquinazoline derivatives and medical uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
JOP20200267A1 true JOP20200267A1 (ar) | 2020-10-25 |
Family
ID=62062935
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JOP/2020/0267A JOP20200267A1 (ar) | 2018-04-24 | 2019-04-23 | طريقة لتحضير (4s)-4-(4-سيانو-2-ميثوكسي فنيل)-5- إيثوكسي-8،2- ثنائي ميثيل-4،1- ثنائي هيدرو-1-6-نفثيريدين-3-كربوكس-اميد عن طريق فصل راسيمات بواسطة استرات حمض طرطريك دياستريومرية |
Country Status (19)
Country | Link |
---|---|
US (1) | US20210163474A1 (ar) |
EP (2) | EP3560922A1 (ar) |
JP (1) | JP7394785B2 (ar) |
KR (1) | KR20210005000A (ar) |
CN (1) | CN112041318A (ar) |
AR (1) | AR114833A1 (ar) |
AU (1) | AU2019258116A1 (ar) |
BR (1) | BR112020018738A2 (ar) |
CA (1) | CA3097924A1 (ar) |
CL (1) | CL2020002742A1 (ar) |
CO (1) | CO2020013150A2 (ar) |
IL (1) | IL278078B2 (ar) |
JO (1) | JOP20200267A1 (ar) |
MX (1) | MX2020011198A (ar) |
PE (1) | PE20211903A1 (ar) |
SG (1) | SG11202010504QA (ar) |
TW (1) | TW202003514A (ar) |
UY (1) | UY38197A (ar) |
WO (1) | WO2019206909A1 (ar) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JOP20220091A1 (ar) * | 2019-10-17 | 2023-01-30 | Bayer Ag | عملية لتحضير 2-سيانو إثيل (4s)-4-(4-سيانو-2-مثوكسي فنيل)-5-هيدروكسي-2، 8-ثنائي مثيل-1، 4-ثنائي هيدرو-1، 6- نفثيريدين-3- كربوكسيلات باستبانة مركبات راسيمية بواسطة إسترات حمض طرطريك صنوية فراغية |
WO2021254896A1 (en) | 2020-06-16 | 2021-12-23 | Bayer Aktiengesellschaft | Process for preparing (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide enabled by a catalytic asymmetric hantzsch ester reduction |
CN115340539B (zh) * | 2022-01-19 | 2024-02-27 | 奥锐特药业股份有限公司 | 制备非奈利酮及其中间体的方法 |
CN115340540A (zh) * | 2022-01-20 | 2022-11-15 | 奥锐特药业股份有限公司 | 制备非奈利酮及其中间体的方法 |
CN114605410B (zh) * | 2022-04-06 | 2023-12-29 | 浙江科聚生物医药有限公司 | 一种非奈利酮原料药的制备方法 |
WO2023205164A1 (en) | 2022-04-18 | 2023-10-26 | Teva Pharmaceuticals International Gmbh | Processes for the preparation of finerenone |
WO2023223188A1 (en) * | 2022-05-16 | 2023-11-23 | Glenmark Life Sciences Limited | Process for the preparation of finerenone and intermediates thereof |
WO2024075139A1 (en) * | 2022-10-06 | 2024-04-11 | Maithri Drugs Private Limited | A process for preparation of finerenone and intermediates thereof |
WO2024094181A1 (zh) * | 2022-11-04 | 2024-05-10 | 南京威凯尔生物医药科技有限公司 | 通过非对映酒石酸酯拆分外消旋体制备非奈利酮的方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3906460C1 (ar) * | 1989-03-01 | 1990-11-15 | Goedecke Ag, 1000 Berlin, De | |
CA2589099C (en) * | 2004-12-02 | 2014-03-25 | Sk Chemicals Co., Ltd. | Optical resolution method of amlodipine |
CA2634397A1 (en) * | 2005-12-22 | 2007-07-05 | Schering Corporation | Process for the preparation of 6,6-dimethyl-3-azabicyclo[3.1.0|-hexane compounds and enantiomeric salts thereof |
DE102007009494A1 (de) | 2007-02-27 | 2008-08-28 | Bayer Healthcare Ag | Substituierte 4-Aryl-1, 4-dihydro-1,6-naphthyridinamide und ihre Verwendung |
CN101648903A (zh) * | 2009-09-17 | 2010-02-17 | 南京大学 | 一种制备光学活性的氨氯地平对甲苯磺酸盐的方法 |
CN101798280B (zh) * | 2010-03-22 | 2012-05-02 | 河北师范大学 | 一种手性拆分消旋体氨氯地平制备s-(-)-氨氯地平和r-(+)-氨氯地平的方法 |
HUE051350T2 (hu) | 2014-08-01 | 2021-03-01 | Bayer Pharma AG | Eljárás (4S)-4-(4-ciano-2-metoxifenil)-5-etoxi-2,8-dimetil-1,4-dihidro-1,6-naftridin-3-karboxamid elõállítására és tisztítására gyógyászati hatóanyagként való alkalmazása céljából |
AU2016311135C1 (en) * | 2015-08-21 | 2022-10-13 | Bayer Pharma Aktiengesellschaft | Method for the preparation of (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carboxamide and recovery of (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carboxamide by electrochemical methods |
TWI725045B (zh) * | 2015-08-21 | 2021-04-21 | 德商拜耳製藥股份有限公司 | 製備(4s)-4-(4-氰基-2-甲氧基苯基)-5-乙氧基-2,8-二甲基-1,4-二氫-1,6-萘啶-3-羧醯胺之方法及其純化用於作為醫藥活性成分 |
-
2018
- 2018-04-24 EP EP18169052.0A patent/EP3560922A1/de not_active Ceased
-
2019
- 2019-04-22 TW TW108113944A patent/TW202003514A/zh unknown
- 2019-04-23 JP JP2020558978A patent/JP7394785B2/ja active Active
- 2019-04-23 US US17/050,303 patent/US20210163474A1/en active Pending
- 2019-04-23 JO JOP/2020/0267A patent/JOP20200267A1/ar unknown
- 2019-04-23 BR BR112020018738-0A patent/BR112020018738A2/pt unknown
- 2019-04-23 MX MX2020011198A patent/MX2020011198A/es unknown
- 2019-04-23 CN CN201980028160.8A patent/CN112041318A/zh active Pending
- 2019-04-23 KR KR1020207030052A patent/KR20210005000A/ko active Search and Examination
- 2019-04-23 IL IL278078A patent/IL278078B2/en unknown
- 2019-04-23 CA CA3097924A patent/CA3097924A1/en active Pending
- 2019-04-23 WO PCT/EP2019/060368 patent/WO2019206909A1/de unknown
- 2019-04-23 EP EP19720516.4A patent/EP3784668A1/de active Pending
- 2019-04-23 SG SG11202010504QA patent/SG11202010504QA/en unknown
- 2019-04-23 AU AU2019258116A patent/AU2019258116A1/en active Pending
- 2019-04-23 PE PE2020001634A patent/PE20211903A1/es unknown
- 2019-04-24 UY UY0001038197A patent/UY38197A/es unknown
- 2019-04-24 AR ARP190101082A patent/AR114833A1/es unknown
-
2020
- 2020-10-21 CO CONC2020/0013150A patent/CO2020013150A2/es unknown
- 2020-10-22 CL CL2020002742A patent/CL2020002742A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
CO2020013150A2 (es) | 2020-11-10 |
IL278078B2 (en) | 2023-10-01 |
AU2019258116A1 (en) | 2020-11-05 |
TW202003514A (zh) | 2020-01-16 |
SG11202010504QA (en) | 2020-11-27 |
IL278078A (en) | 2020-11-30 |
CA3097924A1 (en) | 2019-10-31 |
EP3784668A1 (de) | 2021-03-03 |
IL278078B1 (en) | 2023-06-01 |
CL2020002742A1 (es) | 2021-01-15 |
EP3560922A1 (de) | 2019-10-30 |
BR112020018738A2 (pt) | 2021-01-05 |
UY38197A (es) | 2019-11-29 |
JP7394785B2 (ja) | 2023-12-08 |
CN112041318A (zh) | 2020-12-04 |
PE20211903A1 (es) | 2021-09-27 |
WO2019206909A1 (de) | 2019-10-31 |
JP2021522236A (ja) | 2021-08-30 |
KR20210005000A (ko) | 2021-01-13 |
US20210163474A1 (en) | 2021-06-03 |
MX2020011198A (es) | 2020-11-13 |
AR114833A1 (es) | 2020-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JOP20200267A1 (ar) | طريقة لتحضير (4s)-4-(4-سيانو-2-ميثوكسي فنيل)-5- إيثوكسي-8،2- ثنائي ميثيل-4،1- ثنائي هيدرو-1-6-نفثيريدين-3-كربوكس-اميد عن طريق فصل راسيمات بواسطة استرات حمض طرطريك دياستريومرية | |
MX367959B (es) | Procedimiento para la preparacion de (4s)-4-(4-ciano-2-metoxifenil o)-5-etoxi-2,8-dimetil-1,4-dihidro-1,6-naftiridina-3-carboxamida y para la recuperacion de (4s)-4-(4-ciano-2-metoxifenilo)-5-etoxi- 2,8-dimetil-1,4-dihidro-1,6-naftiridina-3-carboxamida por medio de metodos electroquimicos. | |
MX2017001507A (es) | Procedimiento para la preparacion de (4s)-4-(4-ciano-2-metoxifenil )-5-etoxi-2,8-dimetil-1,4-dihidro-1,6-naftiridin-3-carbox-amida y su purificacion para su uso como principio activo farmceutico. | |
HUE061702T2 (hu) | Racém nikotin enantiomer elválasztása egy alacsony optikai tisztaságú O,O'-diszubsztituált borkõsav hozzáadásával | |
MX2022009299A (es) | Derivado de quinolina muy puro y metodo para su produccion. | |
MX2018010199A (es) | Proceso para la separacion de enantiomeros de derivados de piperazina. | |
MX2018002027A (es) | Procedimiento para la preparacion de (4s)-4-(4-ciano-2-metoxifenil o)-5-etoxi-2,8-dimetilo-1,4-dihidro-1,6-naftiridina-3-carboxamida y su purificacion para su uso como principio activo farmaceutico. | |
MX2022004468A (es) | Procedimiento para la preparacion de (4s)-4-(4-ciano-2-metoxi-feni l)-5-hidroxi-2,8-dimetil-1,4-dihidro-1,6-naftiridin-3-carboxilato de 2-cianoetilo por separacion de racematos por medio de ester de acido tartarico diastereoisomero. | |
NZ728623A (en) | Novel sulfonylaminobenzamide compounds as anthelmintics | |
MX349985B (es) | Procedimiento de preparación de ésteres de fenilacetil aminoácido espirocíclicos con sustitución cis-alcoxi y derivados de 1h-pirrolidin-2,4-diona espirocicíclicos con sustitución cis-alcoxi. | |
LT2012082A (lt) | Nauji fotochrominiai junginiai, jų gamybos būdas ir tarpiniai junginiai jiems gauti | |
MX2022002568A (es) | Proceso para preparar (r)-4-aminoindano y amidas correspondientes. | |
ZA201801865B (en) | Method for the preparation of the metabolites of (4s)- and (4r)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide and the use thereof | |
UA111777C2 (uk) | Спосіб стереоселективного отримання піразолкарбоксаміду | |
IN2013MU02337A (ar) |